{"title":"一级预防心源性猝死患者的危险因素与心脏结局的关联:HINODE研究亚组分析","authors":"Hiroshi Hayashi, Wataru Shimizu, Yuki Iwasaki, Kenji Ando, Kengo Kusano, Toru Asai, Koichi Inoue, Yukihiro Inamura, Takanori Ikeda, Takeshi Mitsuhashi, Toyoaki Murohara, Nobuhiro Nishii, Akihiko Nogami, Torri Schwartz, Torsten Kayser, Yasushi Sakata, Kazutaka Aonuma","doi":"10.1111/jce.70046","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Primary analysis of the HINODE study revealed that mortality and ventricular tachyarrhythmia event rates for patients with primary prevention of sudden cardiac death in Japan were comparable to those of Western patients. Sub-analysis aimed to evaluate event rates in relation to accumulated risk factors (RFs) (left ventricular ejection fraction ≤ 35%, New York Heart Association class III/IV, left bundle branch block/wide QRS, renal dysfunction, diabetes, atrial fibrillation, myocardial infarction, age > 70 years, and smoking).</p><p><strong>Methods and results: </strong>Implantable cardioverter defibrillator (ICD) (N = 102) and cardiac resynchronization therapy-defibrillator (CRT-D) (N = 69) enrollees were evaluated for first appropriately treated ventricular tachycardia or fibrillation (VT/VF), recurrent heart failure (HF) hospitalizations, and all-cause mortality. Event rates were compared for patients with lower-risk (2-3 RFs) and higher-risk (4-5 RFs) using time to event analyses. The ICD-cohort contained 50 (49%) lower-risk and 52 (51%) higher-risk patients, and the CRT-D-cohort 21 (30%) lower-risk and 48 (70%) higher-risk patients. Over 24 months, no significant difference was observed in the VT/VF event rate among the higher-risk group compared to the lower-risk group for either device cohort (ICD: 17% vs. 10%, p = 0.61; CRT-D: 6% vs. 5%, p = 0.79). Similarly, no significant difference was observed in the rate of all-cause mortality, although higher-risk patients trended towards more mortality (ICD: 15% vs. 7%, p = 0.15; CRT-D: 13% vs. 5%, p = 0.33) For the ICD cohort, the risk of HF hospitalization was 2.24 (95% CI: 1.24-4.03) times greater in the higher-risk group compared to the lower-risk group and among those hospitalized for HF, the length of stay was significantly longer for the higher-risk group (median 27 days per year vs. 10 days per year, p = 0.013). No significant difference in the rate of HF hospitalizations was detected for the CRT-D cohort.</p><p><strong>Conclusion: </strong>The implantation of ICD should be considered despite the number of RFs to prevent sudden cardiac death. Proper CRT-D implantation may reduce the number of RFs over time and shorten the duration of HF-hospitalization.</p>","PeriodicalId":15178,"journal":{"name":"Journal of Cardiovascular Electrophysiology","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Association of Risk Factors and Cardiac Outcomes in Patients With Primary Prevention of Sudden Cardiac Death: HINODE Study Sub Analysis.\",\"authors\":\"Hiroshi Hayashi, Wataru Shimizu, Yuki Iwasaki, Kenji Ando, Kengo Kusano, Toru Asai, Koichi Inoue, Yukihiro Inamura, Takanori Ikeda, Takeshi Mitsuhashi, Toyoaki Murohara, Nobuhiro Nishii, Akihiko Nogami, Torri Schwartz, Torsten Kayser, Yasushi Sakata, Kazutaka Aonuma\",\"doi\":\"10.1111/jce.70046\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Primary analysis of the HINODE study revealed that mortality and ventricular tachyarrhythmia event rates for patients with primary prevention of sudden cardiac death in Japan were comparable to those of Western patients. Sub-analysis aimed to evaluate event rates in relation to accumulated risk factors (RFs) (left ventricular ejection fraction ≤ 35%, New York Heart Association class III/IV, left bundle branch block/wide QRS, renal dysfunction, diabetes, atrial fibrillation, myocardial infarction, age > 70 years, and smoking).</p><p><strong>Methods and results: </strong>Implantable cardioverter defibrillator (ICD) (N = 102) and cardiac resynchronization therapy-defibrillator (CRT-D) (N = 69) enrollees were evaluated for first appropriately treated ventricular tachycardia or fibrillation (VT/VF), recurrent heart failure (HF) hospitalizations, and all-cause mortality. Event rates were compared for patients with lower-risk (2-3 RFs) and higher-risk (4-5 RFs) using time to event analyses. The ICD-cohort contained 50 (49%) lower-risk and 52 (51%) higher-risk patients, and the CRT-D-cohort 21 (30%) lower-risk and 48 (70%) higher-risk patients. Over 24 months, no significant difference was observed in the VT/VF event rate among the higher-risk group compared to the lower-risk group for either device cohort (ICD: 17% vs. 10%, p = 0.61; CRT-D: 6% vs. 5%, p = 0.79). Similarly, no significant difference was observed in the rate of all-cause mortality, although higher-risk patients trended towards more mortality (ICD: 15% vs. 7%, p = 0.15; CRT-D: 13% vs. 5%, p = 0.33) For the ICD cohort, the risk of HF hospitalization was 2.24 (95% CI: 1.24-4.03) times greater in the higher-risk group compared to the lower-risk group and among those hospitalized for HF, the length of stay was significantly longer for the higher-risk group (median 27 days per year vs. 10 days per year, p = 0.013). No significant difference in the rate of HF hospitalizations was detected for the CRT-D cohort.</p><p><strong>Conclusion: </strong>The implantation of ICD should be considered despite the number of RFs to prevent sudden cardiac death. Proper CRT-D implantation may reduce the number of RFs over time and shorten the duration of HF-hospitalization.</p>\",\"PeriodicalId\":15178,\"journal\":{\"name\":\"Journal of Cardiovascular Electrophysiology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-08-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cardiovascular Electrophysiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/jce.70046\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiovascular Electrophysiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/jce.70046","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
简介:HINODE研究的初步分析显示,日本心源性猝死一级预防患者的死亡率和室性心动过速事件发生率与西方患者相当。亚分析旨在评估与累积危险因素(RFs)相关的事件发生率(左室射血分数≤35%,纽约心脏协会III/IV级,左束支传导阻滞/宽QRS,肾功能障碍,糖尿病,心房纤颤,心肌梗死,年龄0 ~ 70岁,吸烟)。方法和结果:对植入式心律转复除颤器(ICD) (N = 102)和心脏再同步化除颤器(CRT-D) (N = 69)入组者进行首次适当治疗的室性心动过速或颤动(VT/VF)、复发性心力衰竭(HF)住院和全因死亡率的评估。使用时间到事件分析比较低风险(2-3次射频)和高风险(4-5次射频)患者的事件发生率。icd队列包含50例(49%)低危患者和52例(51%)高危患者,crt - d队列包含21例(30%)低危患者和48例(70%)高危患者。在24个月的时间里,两种器械队列中高危组与低危组的VT/VF事件发生率没有显著差异(ICD: 17% vs. 10%, p = 0.61; CRT-D: 6% vs. 5%, p = 0.79)。同样,在全因死亡率方面也没有观察到显著差异,尽管高风险患者的死亡率倾向于更高(ICD: 15% vs. 7%, p = 0.15;在ICD队列中,高危组的HF住院风险是低危组的2.24倍(95% CI: 1.24-4.03),在因HF住院的患者中,高危组的住院时间明显更长(中位数为每年27天对每年10天,p = 0.013)。在CRT-D组中,没有发现HF住院率的显著差异。结论:即使发生了多次心律失常,仍应考虑植入术,防止心源性猝死。适当的CRT-D植入可减少rf的数量,缩短hf住院时间。
Association of Risk Factors and Cardiac Outcomes in Patients With Primary Prevention of Sudden Cardiac Death: HINODE Study Sub Analysis.
Introduction: Primary analysis of the HINODE study revealed that mortality and ventricular tachyarrhythmia event rates for patients with primary prevention of sudden cardiac death in Japan were comparable to those of Western patients. Sub-analysis aimed to evaluate event rates in relation to accumulated risk factors (RFs) (left ventricular ejection fraction ≤ 35%, New York Heart Association class III/IV, left bundle branch block/wide QRS, renal dysfunction, diabetes, atrial fibrillation, myocardial infarction, age > 70 years, and smoking).
Methods and results: Implantable cardioverter defibrillator (ICD) (N = 102) and cardiac resynchronization therapy-defibrillator (CRT-D) (N = 69) enrollees were evaluated for first appropriately treated ventricular tachycardia or fibrillation (VT/VF), recurrent heart failure (HF) hospitalizations, and all-cause mortality. Event rates were compared for patients with lower-risk (2-3 RFs) and higher-risk (4-5 RFs) using time to event analyses. The ICD-cohort contained 50 (49%) lower-risk and 52 (51%) higher-risk patients, and the CRT-D-cohort 21 (30%) lower-risk and 48 (70%) higher-risk patients. Over 24 months, no significant difference was observed in the VT/VF event rate among the higher-risk group compared to the lower-risk group for either device cohort (ICD: 17% vs. 10%, p = 0.61; CRT-D: 6% vs. 5%, p = 0.79). Similarly, no significant difference was observed in the rate of all-cause mortality, although higher-risk patients trended towards more mortality (ICD: 15% vs. 7%, p = 0.15; CRT-D: 13% vs. 5%, p = 0.33) For the ICD cohort, the risk of HF hospitalization was 2.24 (95% CI: 1.24-4.03) times greater in the higher-risk group compared to the lower-risk group and among those hospitalized for HF, the length of stay was significantly longer for the higher-risk group (median 27 days per year vs. 10 days per year, p = 0.013). No significant difference in the rate of HF hospitalizations was detected for the CRT-D cohort.
Conclusion: The implantation of ICD should be considered despite the number of RFs to prevent sudden cardiac death. Proper CRT-D implantation may reduce the number of RFs over time and shorten the duration of HF-hospitalization.
期刊介绍:
Journal of Cardiovascular Electrophysiology (JCE) keeps its readership well informed of the latest developments in the study and management of arrhythmic disorders. Edited by Bradley P. Knight, M.D., and a distinguished international editorial board, JCE is the leading journal devoted to the study of the electrophysiology of the heart.